Crossmark

Optimizing Isotretinoin Treatment of Acne: Update on Current Recommendations for Monitoring, Dosing, Safety, Adverse Effects, Compliance, and Outcomes

Crossref DOI link: https://doi.org/10.1007/s40257-020-00508-0

Published Online: 2020-02-27

Published Print: 2020-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Landis, Megan N. https://orcid.org/0000-0003-4516-2268
License Information

Text and Data Mining valid from 2020-02-27

Version of Record valid from 2020-02-27
More Information

Article History

First Online: 27 February 2020

Compliance with Ethical Standards

:

: No sources of funding were provided for this manuscript.

: Megan N. Landis has served on advisory boards for Mayne and Janssen, and as an investigator for Galderma, Novartis, Pfizer, and Foamix.

Document is current

Any future updates will be listed below